Option chain shows key data for Japan Food Tech Holdings's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Japan Food Tech Holdings.

Japan Food Tech Holdings (OTC:JFTH) Stock, Option Chain

Japan Food Tech Holdings Inc formerly Dr. Foods Inc, acts as an importer, reseller, developer, and manufacturer of various plant-based food products to replace traditional animal products while retaining the taste and texture of the original.

JAPAN FOOD TECH HLDGS by Japan Food Tech Holdings, Inc.

Japan Food Tech Holdings Inc

Geopark Ltd (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GPRK#NYSE">GPRK</a>) shares are trading higher premarket on Friday. The company disclosed that it has signed Sale and Purchase Agreements with Repsol Exploración S.A. and Repsol E&amp;P S.A.R.L to acquire Repsol&#8217;s <a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/b42238963/geopark-announces-exclusive-binding-agreement-to-acquire-repsol-exploration-and-production-assets-" rel="noreferrer noopener">upstream oil and gas assets in Colombia</a>.
The total consideration for the potential acquisition is approximately $530 million, which will be funded through a mix of cash resources and debt.
This includes a non-recourse amortizing debt facility of up to $345 million, led and arranged by Macquarie Bank Limited, highlighting the assets&#8217; secure and strong cash generation profile.
The acquisition includes assets in Colombia&#8217;s Llanos Basin. It covers 100% of Repsol Colombia O&amp;G Limited, holding a 45% stake in the CPO-9 Block (operated by Ecopetrol), and a 25% interest in SierraCol Energy Arauca LLC.
Combined production from these assets was approximately 16,000 boepd net to Repsol as of September 2024.
This acquisition aligns with GeoPark&#8217;s &#8220;North Star&#8221; growth strategy, providing access to valuable, competitively advantaged assets in proven basins.
The transaction is contingent on the satisfaction of certain conditions and customary regulatory approvals, including the waiver or non-execution of preemptive rights by Repsol&#8217;s current partners.
GeoPark had a cash balance of $123.4 million <a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/b41788517/geopark-reports-third-quarter-2024-results" rel="noreferrer noopener">at the end of September</a>.
Price Action: GPRK shares are up 2.20% at $9.29 premarket at the last check Friday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com//node/42240838" target="_blank" rel="noreferrer noopener">Alibaba&#8217;s New AI Model Outperforms OpenAI&#8217;s o1 In Specific Benchmarks, Now Available For Free Download</a></li>
</ul>
Photo via Shutterstock.

Equities

News

Small Cap

GPRK

GeoPark Seals $530 Million Colombian Oil & Gas Asset Acquisition Deal With Repsol

Citigroup analyst Kelly Crago maintains Ulta Beauty (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ULTA#NASDAQ">ULTA</a>) with a Neutral and raises the price target from $345 to $390.

Price Target

Analyst Ratings

ULTA

Citigroup Maintains Neutral on Ulta Beauty, Raises Price Target to $390

U.S. stock futures advanced on Friday after a day&#8217;s break for Thanksgiving as investors look to end November on a high note. The dollar slipped below the 106 mark in the hope of more measured tariffs.
U.S. markets will close at 1 p.m. ET on Friday during the truncated week.
Futures for the three major U.S. indices gained, while the two-year and 10-year treasury yields eased on Friday. The expectations of a further 25 basis point rate cut in December rose to 66%, according to <a href="https://www.cmegroup.com/markets/interest-rates/cme-fedwatch-tool.html">CME Group&#8217;s FedWatch tool</a>.
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Futures</td>
<td>Performance (+/-)</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>0.37%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>0.27%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>0.32%</td>
</tr>
<tr>
<td>R2K</td>
<td>0.81%</td>
</tr>
</tbody>
</table>
</figure>
In premarket trading on Friday, the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) was up 0.31% to $600.69 and the Invesco QQQ Trust ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NYSE">QQQ</a>) rose 0.44% to $507.50, according to <a href="https://www.benzinga.com/pro/">Benzinga Pro data</a>.
Cues From The Last Session
The S&amp;P 500 index fell 22.89 points or 0.38% to end at 5,998.74. The Dow Jones Industrial Average lost 138.25 points or 0.31% to close at 44,722.06 and the Nasdaq Composite Index dropped 115.10 points or 0.60% to 19,060.48. The 10-year Treasury note yield dropped six basis points to 4.24%, a one-month low close
On the economic front, the U.S. core PCE price index increased by 0.3% month-over-month in October, the same pace as in the previous month, in line with market estimates. U.S. initial jobless claims came in unchanged at 213,000 for the week ending Nov. 23, compared to market estimates of 216,000.
Pending home sales rose 2% month-over-month in October compared to a revised 7.5% gain in September.
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Index</td>
<td>Performance (+/-)</td>
<td>Value</td>
</tr>
<tr>
<td>Nasdaq Composite</td>
<td>-0.60%</td>
<td>19,060.48</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>-0.38%</td>
<td>5,998.74</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>-0.31%</td>
<td>44,722.06 </td>
</tr>
<tr>
<td>Russell 2000</td>
<td>0.08%</td>
<td>2,426.19</td>
</tr>
</tbody>
</table>
</figure>
Insights From Analysts
Markets have been under pressure only <a href="https://www.benzinga.com/24/11/42239447/markets-flopped-in-december-only-once-in-95-years-but-a-bearish-crossover-flagging-market-fall-is-on-the-cards-heres-what-analysts-say">once in December over the last 95 years</a>, according to the data highlighted by Ryan Detrick, chief market strategist at Carson Group.
Detrick highlighted data from 1928 to 2023 to show that while September has been the worst month for equities 13 times during this period, December was the worst only once in these 95 years. As far as 2024 is concerned, April has been the worst month so far with a 4% drop.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Something to be thankful for? December has been the worst month of the year for stocks only once going back 95 years (2018 and the Fed policy mistake). Worst month this year has been the 4% drop in April. <a href="https://t.co/2ThL3DwD7x">pic.twitter.com/2ThL3DwD7x</a>
&mdash; Ryan Detrick, CMT (@RyanDetrick) <a href="https://twitter.com/RyanDetrick/status/1862188406505185730?ref_src=twsrc%5Etfw">November 28, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Also read: <a href="https://www.benzinga.com/24/11/42239447/markets-flopped-in-december-only-once-in-95-years-but-a-bearish-crossover-flagging-market-fall-is-on-the-cards-heres-what-analysts-say">Wall Street&#8217;s December Surprise: What Investors Need to Know Now</a>
On the other hand, David Cox, CMT, CFA, portfolio manager at Raymond James, in an X Post highlighted the likelihood of an upcoming to the investors, saying "If you want to sidestep a decline, watch the trend…"
The 13/34-week Exponential Moving Average signals a bullish market trend when the 13-week EMA line is above the 34-week EMA line and a bullish crossover results in a market correction. Predicting an upcoming crossover through his chart Cox said that "there will be another red circle some day." The red circle in his chart represents a bullish crossover.
According to a note by CMGWealth, the 13/34-week EMA analysis is a "simple, tactical trend indicator that has historically captured the cyclical bull and bear market trends."
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">again, look at how much easier we can make it on ourselves&#8230; time frame matters, if you want to sidestep a decline, watch the trend&#8230; look at these 13/34-week EMA <a href="https://twitter.com/hashtag/bearish?src=hash&amp;ref_src=twsrc%5Etfw">#bearish</a> crossovers&#8230; they help you remove emotion, and stay focused&#8230; there will be another red circle some day <a href="https://t.co/kpAXx8F5jX">pic.twitter.com/kpAXx8F5jX</a>
&mdash; David Cox, CMT, CFA (@DavidCoxRJ) <a href="https://twitter.com/DavidCoxRJ/status/1861758050215891069?ref_src=twsrc%5Etfw">November 27, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Upcoming Economic Data
There are no scheduled economic events or data scheduled to be released today.
Stocks To Watch:
<ul>
<li>Cabaletta Bio Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CABA#NASDAQ">CABA</a>) <a href="https://www.benzinga.com/markets/equities/24/11/42229129/caballeta-bio-shares-surge-the-most-in-23-months-in-a-single-day-as-it-unveils-plan-to-meet-fda-by-2025-for-systemic-sclerosis-drug-trial">shares rose</a> by 11.63% to $3.36 per share in premarket following an update on their Systemic Sclerosis drug trial. The company anticipates meeting the U.S. Food and Drug Administration in 2025 to discuss potential registrational trial designs, as per a notice by DelveInsight Business Research.</li>
<li>Frontline Plc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FRO#NYSE">FRO</a>) shares were down 2.38% to $16.78 per share following mixed third-quarter results. Revenue rose 29.9% year-over-year to $490.4 million, surpassing the $361.42 million consensus.</li>
<li>Rigetti Computing, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGTI#NASDAQ">RGTI</a>) jumped 8.33% to $2.60 apiece in pre-market trading after rising by 9% on Tuesday. Shares continued an up move as the company announced a registered direct offering of 50 million shares at $2 per unit aiming to raise $100 million in gross proceeds.</li>
<li>ZenaTech Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZENA#NASDAQ">ZENA</a>) fell by 6.89% to $7.30 apiece. The stock was pulling back after surging on Tuesday. Last Thursday its subsidiary, ZenaDrone, signed agreements ensuring compliance with Blue Unmanned Aerial Systems (UAS) and the U.S. National Defense Authorization Act (NDAA.)</li>
<li>Bitdeer Technologies Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTDR#NASDAQ">BTDR</a>) shares were up 7.52% to $13.15 per share after it announced a private placement of $360 million in Convertible Senior Notes, aiming to finance data center expansion and the development of crypto mining rigs.</li>
</ul>
Commodities, Gold And Global Equity Markets:
Crude oil futures fell in the early New York session, declining 0.60% to hover around $68.30.
The Gold spot rose 0.94% to 2,662.10 per ounce.
Asian markets were mixed as major indices in Japan, Australia, and South Korea fell, whereas Hong Kong, China, and Indian markets closed higher. European markets were also mixed in early trading.
Read Next:
<ul>
<li><a href="http://gop%20megadonor%20ken%20griffin%20slashes%20citadel's%20palantir%20stake%20by%2091%25,%20bets%20big%20on%20nvidia%20as%20jensen%20huang-led%20company%20rises%20over%20180%25%20in%202024/" target="_blank" rel="noreferrer noopener">GOP Megadonor Ken Griffin Slashes Citadel's Palantir Stake By 91%, Bets Big On Nvidia As Jensen Huang-Led Company Rises Over 180% In 2024</a></li>
</ul>
Photo courtesy: Wikimedia

Earnings

Futures

Economics

Federal Reserve

Pre-Market Outlook

Markets

Movers

Trading Ideas

BTDR

CABA

RGTI

ZENA

US Stocks Likely To Open In The Green To End November On A High: Are Markets Set For A Santa Claus Rally In December? Analysts Decode

Barclays analyst Blayne Curtis maintains TXNM Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TXNM#NYSE">TXNM</a>) with a Overweight and raises the price target from $46 to $52.

TXNM

Barclays Maintains Overweight on TXNM Energy, Raises Price Target to $52

Barclays analyst Andrew Lazar maintains JM Smucker (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SJM#NYSE">SJM</a>) with a Equal-Weight and raises the price target from $121 to $126.

Barclays Maintains Equal-Weight on JM Smucker, Raises Price Target to $126

On Wednesday, November 27th, U.S. markets ended lower, with the Nasdaq suffering the steepest losses as technology stocks led the decline. Concerns over the Federal Reserve&#8217;s cautious stance on interest rate cuts resurfaced after data indicated stubbornly high U.S. inflation.
According to economic data, the PCE price index rose 2.3% annually in October, up from 2.1%, while core PCE inflation edged higher at 2.8%. Personal spending and income exceeded expectations, and Q3 GDP growth held steady at 2.8%.
Asia Markets Today
<ul>
<li>The Dow Jones Industrial Average was down 0.31% and closed at 44,722.06, the S&amp;P 500 declined 0.38% to 5,998.70, and the Nasdaq Composite dropped 0.60% to finish at 19,060.48.</li>
<li>On Friday, Japan&#8217;s Nikkei 225 declined 0.52% and ended the session at 38,148.50, led by losses in the Shipbuilding, Precision Instruments, and Retail sectors.     </li>
<li>Australia&#8217;s S&amp;P/ASX 200 fell 0.10% and ended the day at 8,436.20, led by losses in the A-REITs, Industrials and Telecoms Services sectors.</li>
<li>India&#8217;s Nifty 50 rose 0.87% to 24,122.85, and Nifty 500 gained 0.72% closing at 22,676.60, led by gains in the Oil &amp; Gas, Auto and Technology sectors.</li>
<li>China&#8217;s Shanghai Composite gained 0.93% to close at 3,326.46, and the Shenzhen CSI 300 rose 1.14%, finishing the day at 3,916.58.</li>
<li>Hong Kong&#8217;s Hang Seng was up 0.29% and closed the session at 19,423.61.</li>
</ul>
Eurozone at 06:00 AM ET
<ul>
<li>The European STOXX 50 index was down 0.03%.</li>
<li>Germany&#8217;s DAX rose 0.12%.</li>
<li>France&#8217;s CAC gained 0.04%.</li>
<li>The FTSE 100 index traded lower by 0.09%.</li>
</ul>
Commodities at 06:00 AM ET
<ul>
<li>Crude Oil WTI was trading lower by 0.51% at $68.37/bbl, and Brent was down 0.82% at $72.17/bbl.</li>
<li>Oil prices fell over 3% this week as the Middle East ceasefire eased supply risks, while 2025 forecasts indicate excess supply despite expected OPEC+ cuts.</li>
<li>Natural Gas gained 3.50% to $3.314.</li>
<li>Gold was trading higher by 0.82% at $2,686.59, Silver was up 1.92% to $31.142, and Copper slid 0.05% to $4.1363.</li>
</ul>
U.S. Futures at 06:00 AM ET
Dow futures gained 0.31%, S&amp;P 500 futures were up 0.30% and Nasdaq 100 futures rose 0.40%.
Forex at 06:00 AM ET
The U.S. dollar index fell 0.18% to 105.95, the USD/JPY was down 1,07% to 149.91, and the USD/AUD slid 0.05% to 1.5379.
Photo by Pavel Bobrovskiy via Shutterstock

Asia

Emerging Markets

Eurozone

Commodities

Forex

ADIV

AGOV

ASHR

BBEU

BOIL

CQQQ

PowerShares DBmmodity Index Optimum Yield Diversified Fund

EEMA

FLAX

CurrencyShares British Pound Sterling Trust

IEMG

IEUR

KraneShares Trust KraneShares S&P Pan Asia Dividend Aristocrats Index ETF

KDIV

SPEM

USDU

PowerShares DB US Dollar Index Bullish Fund

Asia And Europe Markets Mixed; Oil Falls And Dollar Cools - Global Markets Today While US Slept

Barclays analyst Lauren Lieberman maintains Brown-Forman (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BF#NYSE">BF</a>) with a Overweight and lowers the price target from $53 to $49.

BF/B

Barclays Maintains Overweight on Brown-Forman, Lowers Price Target to $49

Taiwan Semiconductor Manufacturing Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) is reportedly set to begin producing its advanced 2-nanometer (2nm) chips in the U.S. by 2028.
Wu Cheng-wen, head of the National Science and Technology Council (NSTC), confirmed the timeline during a legislative hearing when questioned whether Taiwan Semiconductor might start 2nm production in the U.S. before the prescribed period, Focus Taiwan <a target="_blank" href="https://focustaiwan.tw/business/202411290005" rel="noreferrer noopener">reports</a>.
This timeline aligns with Taiwan&#8217;s policy requiring Taiwan Semiconductor to delay exporting cutting-edge technology abroad until three years after it begins mass production domestically.
Also Read: <a target="_blank" href="https://www.benzinga.com/24/11/42089611/taiwan-semiconductor-faces-china-challenges-amid-potential-trump-return-and-geopolitical-tensions" rel="noreferrer noopener">Taiwan Semiconductor Faces China Challenges Amid Potential Geopolitical Tensions From Trump Return</a>
Taiwan&#8217;s government has emphasized the importance of maintaining domestic leadership in semiconductor production before allowing advanced technology exports, the report adds.
Taiwan Semiconductor has already initiated trial production of 2nm chips at its Baoshan facility in Hsinchu County, Taiwan, with mass production slated to begin in 2025. <a target="_blank" href="https://www.benzinga.com//node/42186138" rel="noreferrer noopener">Additional facilities in Kaohsiung</a> will likely start 2nm production in 2026. The company is concurrently constructing two advanced fabs in Arizona, with plans to mass-produce chips using 3nm and 2nm processes in 2028. A third Arizona facility could begin production by 2030. Advanced Micro Devices, Inc. reportedly tapped Taiwan Semiconductor&#8217;s 3nm process to foray into <a target="_blank" href="https://www.benzinga.com/24/11/42210228/taiwan-semiconductor-ramps-up-2nm-production-apple-and-amd-first-in-line" rel="noreferrer noopener">the smartphone market</a>.
The U.S. Department of Commerce recently finalized an agreement granting Taiwan Semiconductor $6.6 billion under the CHIPS Incentives Program. This funding supports Taiwan Semiconductor&#8217;s Arizona operations and includes commitments to deploy <a target="_blank" href="https://www.benzinga.com/24/11/42060003/taiwan-semiconductors-us-subsidy-boosts-a16-tech-production-in-arizona" rel="noreferrer noopener">A16 nanosheet technology</a>. The A16 process features innovative backside power delivery for enhanced performance and logic density. However, like the 2nm technology, the A16 process will also adhere to the three-year rule before production in the U.S.
The contract chipmaker is eying more factories in Kaohsiung, Tainan, and Taichung to ramp up domestic production of <a target="_blank" href="https://www.benzinga.com/24/11/42116366/taiwan-semiconductor-plans-new-factories-annually-boosting-domestic-chip-production" rel="noreferrer noopener">advanced technology chips</a>.
Reportedly, Taiwan Semiconductor accounts for 36% of <a target="_blank" href="https://www.benzinga.com/government/24/10/41140484/taiwan-semiconductor-has-soared-96-but-geopolitical-risks-persist" rel="noreferrer noopener">Taiwan&#8217;s index weighting</a>. However, Taiwan Semiconductor remains vulnerable to the budding geopolitical tension between the U.S. and China. While Chinese leader Xi Jinping remains committed to the &#8220;reunification&#8221; with Taiwan, the U.S. sanctions on China forbid Taiwan Semiconductor from importing Nvidia artificial intelligence chips to China.
Taiwan Semiconductor stock gained over 79% year-to-date.
The chipmaker earmarked capital expenditures of $34 billion—$38 billion in 2025 to meet the advanced semiconductor manufacturing demand frenzy.
Price Action: TSM stock closed lower by 1.44% at $181.19 on Wednesday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/24/11/42221416/hp-faces-margin-pressure-but-analysts-see-ai-pcs-driving-growth-in-2025" target="_blank" rel="noreferrer noopener">HP Faces Margin Pressure But Analysts See AI PCs Driving Growth In 2025</a></li>
</ul>
Photo by Sundry Photography on Shutterstock.

Government

Regulations

Tech

Media

Taiwan Semiconductor's Advanced 2nm Chips To Hit US Market By 2028: Report

RVNC

Revance Therapeutics Extends Tender Offer Deadline For Merger With Crown Laboratories To December 3, 2024 Amid Ongoing Discussions

JFBR

Jeffs' Brands Announces Trademark Registration Approval For Wellution, A Wellness And Personal Care Brand (49%) From The USPTO - Wellution's Skin And Hair Care Product Lines

Volkswagen (OTC:<a class="ticker" href="https://www.benzinga.com/stock/VWAGY#OTC">VWAGY</a>)&nbsp;will leverage <a href="https://www.benzinga.com/24/11/41934150/rivian-shares-rise-13-in-pre-market-after-volkswagen-increases-planned-investment-to-58b">its partnership with</a> Rivian&nbsp;Automotive Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIVN#NASDAQ">RIVN</a>) to power its upcoming flagship electric vehicle, codenamed "Project Trinity."
What Happened: This collaboration is part of a $5.8 billion joint venture aimed at integrating Rivian&#8217;s advanced architecture into Volkswagen&#8217;s future models.
According <a href="https://insideevs.com/news/742492/vw-project-trinity-rivian-sdv/">to</a> InsideEVs, Project Trinity, initially delayed, is set to feature Level 4 autonomous driving capabilities. The delay allows Volkswagen to focus on launching an&nbsp;electrified version of the Golf,&nbsp;described as a more &#8220;iconic product.&#8221;
The Golf EV is expected to debut in 2029, with Trinity following at a later date.
Volkswagen CEO Thomas Schafer confirmed the partnership with Rivian during a media roundtable, emphasizing the importance of the new software-defined vehicle architecture.
"We&nbsp;decided on how to do&nbsp;the software-defined vehicle. It&nbsp;will happen with Rivian, the&nbsp;joint venture, where we put the new electric electronics architecture together," said Schafer.
See Also:&nbsp;<a href="https://www.benzinga.com/24/11/42185887/astrophysicist-neil-degrasse-tyson-dismisses-musks-vision-to-build-self-sustaining-city-on-mars?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Astrophysicist Neil deGrasse Tyson Dismisses Elon Musk&#8217;s Mars Vision: SpaceX CEO Hits Back, Says &#8216;They Really Don't Get It'</a>
While Project Trinity is not intended as a mass-market vehicle, it remains a crucial part of Volkswagen&#8217;s strategy to rejuvenate its brand.
The new architecture will first appear in&nbsp;Porsche&nbsp;and&nbsp;Audi&nbsp;models by 2027, eventually extending across the Volkswagen family, including luxury SUVs and compact cars.
Why It Matters: The partnership between Volkswagen and Rivian marks a strategic move for both companies.
The joint venture, officially <a href="https://www.benzinga.com/24/11/41934150/rivian-shares-rise-13-in-pre-market-after-volkswagen-increases-planned-investment-to-58b">launched earlier this month</a>, involves a $5.8 billion investment from Volkswagen, up from the previously announced $5 billion. This increase in investment underscores the importance of the collaboration for Rivian, providing a much-needed boost to its financial stability and growth potential.
The joint venture aims to advance electrical and electronic architecture technology, focusing on electronic control units, network infrastructure, and associated software. This partnership is expected to enhance Rivian&#8217;s capital roadmap, aiding in future growth and vertical integration of its software and electrical systems, according to&nbsp;<a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41938838/rivians-deal-with-volkswagen-will-help-ev-giant-navigate-the-ship-in-stormy-waters-says-top-analyst-maintains-outperform-rating-with-20-target">analysts</a>&nbsp;at Wedbush.
However, the deal has not been without controversy, <a href="https://www.benzinga.com/news/24/09/40772132/volkswagens-5b-deal-with-rivian-leaves-software-arm-cariad-workers-frustrated-ceo-left-out-report">reportedly causing discontent</a> among employees at Volkswagen&#8217;s software division, Cariad.
Price Action: Rivian stock closed at $12.22 on Wednesday, surging 5.8%. In premarket trading on Friday, the stock was up 1.5%. Year-to-date, the Rivian stock has declined by 42%, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro data</a>.
Analysts are bullish on Rivian, with the consensus rating being ‘Buy' on the EV giant's stock. The highest price target is $28, while the lowest is $11. The consensus price target is $16.17, which implies a 32% upside.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/quote/RIVN/analyst-ratings"><img loading="lazy" decoding="async" width="948" height="356" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/29060011/Rivian-Volkswagen.jpg" alt="" class="wp-image-669845" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/29060011/Rivian-Volkswagen.jpg 948w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/29060011/Rivian-Volkswagen-300x113.jpg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/29060011/Rivian-Volkswagen-768x288.jpg 768w" sizes="(max-width: 948px) 100vw, 948px" /></a></figure>
Check out more of Benzinga&#8217;s Future Of Mobility coverage by&nbsp;<a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/global/24/11/42188994/amid-trumps-plans-to-impose-25-tariffs-mexico-fears-byd-new-factory-in-country-would-send-wrong-message-investments-from-china-have-to-be-analyzed-with-extreme-caution?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Amid Trump&#8217;s Plans To Impose 25% Tariffs, Mexico Fears BYD's New Factory In Country Would Send Wrong Message</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo courtesy: Shutterstock

Global

RIVN

VWAGY

Volkswagen Taps Rivian Partnership For Upcoming Flagship EV 'Project Trinity'

RDNT

RadNet's DeepHealth Subsidiary Expands FDA Clearance For SmartMammo Solution; Clearance Enables  RadNet's DeepHealth and GE HealthCare Collaboration To Bring Together The SmartMammo And Senographe Pristina Solutions For Breast Cancer Diagnosis

On Wednesday, Applied Therapeutics, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APLT#NASDAQ">APLT</a>) received an FDA Complete Response Letter (CRL) for the New Drug Application (NDA) for govorestat <a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/g42224414/applied-therapeutics-receives-complete-response-letter-from-u-s-fda-regarding-new-drug-application" rel="noreferrer noopener">for Classic Galactosemia</a>.
Galactosemia is a rare genetic metabolic disease resulting in an inability to metabolize the simple sugar galactose. When not appropriately metabolized, galactose is converted to the toxic metabolite, galactitol, which causes neurological complications.
Also Read: <a target="_blank" href="https://www.benzinga.com/general/biotech/24/09/40921732/applied-therapeutics-stock-soars-as-fda-scraps-panel-meeting-for-its-inherited-metabolic-disorder" rel="noreferrer noopener">Applied Therapeutics Stock Soars As FDA Scraps Panel Meeting For Its Inherited Metabolic Disorder Drug</a>
The CRL indicates that the FDA completed its review of the application and determined that it is unable to approve the NDA in its current form, citing deficiencies in the clinical application.
Applied Therapeutics is reviewing the FDA feedback. It plans to immediately request a meeting to discuss the requirements for a potential resubmission of the NDA or appeal of the decision and appropriate next steps.
In Phase 3 registrational ACTION-Galactosemia Kids study in children with Galactosemia aged 2-17, treatment with govorestat demonstrated clinical benefit on activities of daily living, behavioral symptoms, cognition, fine motor skills, and tremor.
Govorestat also significantly reduced plasma galactitol levels in adults and children with Galactosemia.
Govorestat is also being developed for Sorbitol Dehydrogenase (SORD) Deficiency, a rare and progressive neuromuscular disease. The company expects to submit an NDA early in the first quarter of 2025.
William Blair stated that they were confident in the approval of govorestat ahead of its PDUFA date, given strong clinical data showing its effectiveness for a rare disease with no available treatments. However, the FDA&#8217;s rejection was unexpected and disappointing.
With limited details in the CRL, the next steps for govorestat in treating galactosemia remain unclear, including whether another clinical trial will be required.
As a result, William Blair has lowered its probability of success for the galactosemia program to 30% and delayed the projected U.S. launch to the fourth quarter of 2025, pending further clarification.
Despite this setback, William Blair maintained its Outperform rating, noting that the CRL likely doesn&#8217;t impact the company&#8217;s other program targeting SORD.
They emphasized that the SORD clinical trial met its key goals and offered a stronger data package. Additionally, the FDA&#8217;s alignment on an accelerated approval pathway for SORD suggests that, if granted priority review, govorestat could still begin generating revenue by late 2025.
Price Action: APLT stock is down 67.2% at $2.81 during the premarket session at last check Friday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/biotech/24/11/42222191/donald-trump-nominates-pandemic-critic-jay-bhattacharya-tapped-to-reshape-national-institutes-of-health-that-oversees-budget-of-48-billion" target="_blank" rel="noreferrer noopener">Trump Taps Pandemic Lockdown Critic Jay Bhattacharya To Overhaul NIH</a></li>
</ul>
Illustration of Phrama lab worker created with MidJourney.

Analyst Color

Biotech

Health Care

Reiteration

General

APLT

Regulatory Setback For Applied Therapeutics' Lead Program, FDA Highlights Deficiencies In Clinical Application

Offerings

Management

Insider Trades

BSLK

Bolt Projects Holdings On Wednesday Announced Private Placement With CEO and Other Officers Of 1.06M Shares At $0.34/Share For $360K Gross Proceeds; Closing Expected December 2, 2024

MicroStrategy Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) experienced a notable 4.44% increase in its share price during pre-market trading on Friday as per <a href="https://pro.benzinga.com/">Benzinga Pro</a>. This rise aligns with Bitcoin&#8216;s (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) recovery from its recent dip.
What Happened: Earlier this week, Bitcoin had dropped to $92,000 but was trading at $96,596.96 by 5:26 a.m. ET. The cryptocurrency&#8217;s resurgence seems to have positively impacted MicroStrategy&#8217;s stock performance.
MicroStrategy&#8217;s consensus price target stands at $449.5, based on assessments from 12 analysts. The highest target of $690 was set&nbsp;by BTIG on December 11,&nbsp;2023, while the lowest, $140, was&nbsp;issued by Jefferies on Nov.&nbsp;10, 2022.
See Also:&nbsp;<a href="https://www.benzinga.com/24/11/42206056/bitcoin-ethereum-dogecoin-tumble-as-diamond-hands-lock-in-gains-analyst-anticipates-strong-buyback-pressure-to-follow-sell-pressure?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Bitcoin, Ethereum, Dogecoin Tumble As &#8216;Diamond Hands&#8217; Lock In Gains: Top Analyst Anticipates BTC Rebound</a>
As per Benzinga Pro, the consensus price target for MSTR is $449.5 based on the ratings of 12 analysts. The most recent analyst ratings for MicroStrategy were provided by TD Cowen, Barclays, and Benchmark on Nov. 25. These ratings suggest an average price target of $563.33, indicating a potential upside of 38.72% for the company.
<figure class="wp-block-image size-large"><a href="https://www.benzinga.com/quote/MSTR/analyst-ratings"><img decoding="async" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/29054824/Screenshot-2024-11-29-at-4.18.06%E2%80%AFPM-1024x398.png" alt="" class="wp-image-669815" /></a></figure>
Why It Matters: MicroStrategy&#8217;s stock performance is closely tied to Bitcoin&#8217;s fluctuations due to its substantial investment in the cryptocurrency. The company&#8217;s strategy of acquiring and holding Bitcoin has been both praised and criticized. Recently,&nbsp;economist and market strategist Peter Schiff <a href="https://www.benzinga.com/24/11/42237876/peter-schiff-predicts-microstrategys-bankruptcy-due-to-bitcoin-investment-strategy">predicted potential bankruptcy</a> for MicroStrategy due to its Bitcoin investment approach. In an interview with Kitco News, Schiff described MicroStrategy as a &#8220;great short&#8221; and suggested that the company&#8217;s strategy could ultimately lead to bankruptcy. Schiff&#8217;s comments highlight the risks associated with MicroStrategy&#8217;s heavy reliance on Bitcoin&#8217;s market performance.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/24/11/42228090/bitcoin-ethereum-dogecoin-surge-as-traders-raise-risk-appetite-ahead-of-thanksgiving-analyst-says-eth-could-jump-to-highs-not-seen-since-late-2021?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Bitcoin, Ethereum, Dogecoin Surge As Traders Raise Risk Appetite Ahead Of Thanksgiving: Analyst Sets Mid-Term Price Target For ETH At $6K</a></li>
</ul>
Disclaimer: This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.
Image via Shutterstock

$BTC

MSTR

MicroStrategy Shares Jumps In Friday Pre-Market As Bitcoin Rebounds To $96,000: Consensus Price Target Reveals Over 15% Upside For MSTR

On Wednesday, Envirotech Vehicles, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVTV#NASDAQ">EVTV</a>) disclosed that it delivered two demonstration electric delivery vans to FedEx Delivery Service Partners, including <a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/ac42227275/envirotech-vehicles-inc-nasdaq-evtv-announces-delivery-of-electric-vans-to-fedex" rel="noreferrer noopener">Dreaming Green Corp. in Connecticut</a>.
These mid-roof electric vans will deliver packages to homes and businesses in Connecticut.
With average gasoline prices in Connecticut exceeding $3.00 per gallon and diesel approaching $3.70, Envirotech&#8217;s electric delivery vehicles present an appealing option for fleet-reliant businesses.
Dreaming Green Corp.&#8217;s owner Nelson Pinhancos said, &#8220;We are excited to begin testing the Envirotech electric delivery van. We estimate a monthly savings of $1,800 in fuel and maintenance costs. And the fact we will be generating zero emissions while serving our customers is something we are proud of as a company.&#8221;
&#8220;We expect this test program to be a success. And we look forward to then scaling up our Envirotech electric fleet. Other FedEx DSPs have already shown interest in joining us.&#8221;
Phil Oldridge, CEO of Envirotech, stated, &#8220;Envirotech is proud to serve business owners from California to Connecticut as we help them reduce their operating costs and increase their on-time delivery performance.&#8221; &#8220;First mile, last mile delivery companies know how impactful monthly saving of one to two thousand dollars per vehicle is for their bottom line. And successful deliveries with no emissions are a mark of pride for every owner of an Envirotech vehicle.&#8221;
This week, Envirotech Vehicles disclosed plans to access $25 million in funding from <a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/ac42201399/envirotech-vehicles-inc-nasdaq-evtv-expects-to-access-25-million-in-funding-from-yorkville-adviso" rel="noreferrer noopener">Yorkville Advisors Global LP</a>.
Price Action: EVTV shares closed higher by 6.67% at $1.44 on Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com//node/42240301" target="_blank" rel="noreferrer noopener">Elon Musk Lauds Apple AirPods Pro 2&#8217;s Hearing Aid Feature As Tim Cook Highlights The Affordable Solution To What Otherwise Costs Up To $7,000</a></li>
</ul>

EVTV

FedEx Delivery Service Partners Test Envirotech Electric Vans In Connecticut: Details

Nordic American Tankers Reports Strong Q3 2024 with $8.7M Profit, $125M in New Long-Term Contracts, and 109th Consecutive Dividend; Fleet Expansion Planned

Macro Economic Events

Econ #s

INDA

India Gross Domestic Product Quarterly (YoY) For Q2 5.4% Vs. 6.5% Est.; 6.7% Prior

Alibaba Group Holding Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>) has introduced a new AI model, QwQ-32B-Preview, which is positioned as a competitor to Microsoft Corp.-backed (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) OpenAI&#8217;s o1 <a href="https://www.benzinga.com/top-stories/24/09/40842891/openai-unveils-o1-model-a-step-closer-to-human-like-ai-but-not-without-flaws">reasoning model</a>.
What Happened: Developed by Alibaba&#8217;s Qwen team, QwQ-32B-Preview boasts 32.5 billion parameters, enabling it to handle prompts up to 32,000 words.
This model is one of the few available under a permissive license, allowing for download and use, the company stated in a blog post on Thursday.
It reportedly outperforms OpenAI&#8217;s o1-preview and o1-mini models on specific benchmarks, such as the AIME and MATH tests. These tests evaluate AI models&#8217; performance in logic puzzles and math problems.
See Also: <a href="https://www.benzinga.com/trading-ideas/movers/24/11/42169194/joby-gets-toyotas-500m-dollar-lift-evtol-pioneer-making-new-highs?itm_source=parsely-api">Joby Gets Toyota&#8217;s $500M Dollar Lift: eVTOL Pioneer Making New Highs</a>
Despite its strengths, QwQ-32B-Preview has limitations. Alibaba acknowledges potential issues like unexpected language switches and underperformance in tasks requiring common sense reasoning.
The model&#8217;s reasoning capabilities allow it to fact-check itself, reducing errors but increasing solution time.
QwQ-32B-Preview is available on the AI development platform Hugging Face.
However, only certain components are released, limiting full replication or insight into its workings. The model&#8217;s responses align with Chinese regulatory standards, avoiding politically sensitive topics.
The development was first <a href="https://techcrunch.com/2024/11/27/alibaba-releases-an-open-challenger-to-openais-o1-reasoning-model/">spotted</a> by TechCrunch.
Subscribe to the&nbsp;<a href="https://bztechtrends.beehiiv.com/subscribe" target="_blank" rel="noreferrer noopener">Benzinga Tech Trends newsletter</a>&nbsp;to get all the latest tech developments delivered to your inbox.
Why It Matters: The introduction of Alibaba&#8217;s QwQ-32B-Preview comes at a time when OpenAI is making significant strides in the AI sector. Last month, OpenAI&#8217;s valuation <a href="https://www.benzinga.com/news/24/10/41149788/openai-valuation-soars-to-157b-in-latest-funding-round">soared to $157 billion </a>following a successful funding round.&nbsp;
Earlier this week, it was reported that SoftBank Group (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SFTBF#OTC">SFTBF</a>) has increased its stake in OpenAI through a <a href="https://www.benzinga.com/markets/equities/24/11/42227972/softbank-secures-bigger-openai-stake-with-1-5b-employee-share-buyout-report">$1.5 billion employee share buyout</a>.
OpenAI is also reportedly exploring the <a href="https://www.benzinga.com/markets/24/11/42130303/chatgpt-parent-openai-considers-building-its-own-web-browser-to-challenge-googles-search-monopoly-following-doj-push-to-break-up-chrome-dominance">development of its own web browser</a> to challenge Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) subsidiary Google&#8217;s Chrome browser, following a push from the U.S. Department of Justice to divest it.
Price Action: Currently, Alibaba shares are up 0.27% to $86.82 in pre-market trading on Friday, following a 1.66% rise to $86.59 during Wednesday&#8217;s regular session, according to <a href="https://pro.benzinga.com/dashboard">data from Benzinga Pro</a>.
Check out more of Benzinga&#8217;s Consumer Tech coverage by&nbsp;<a href="https://www.benzinga.com/topic/consumer-tech" target="_blank" rel="noreferrer noopener">following this link</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/24/11/42053396/why-chinese-tech-giants-alibaba-bytedance-and-meituan-are-expanding-their-ai-footprints-in-silicon-valley-amid-us-efforts-to-block-progress?itm_source=parsely-api">China&#8217;s Tech Giants Alibaba, ByteDance, And Meituan Are Expanding Their Silicon Valley AI Footprints Amid US Efforts To Block Progress: Here&#8217;s Why</a></li>
</ul>
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo courtesy: Shutterstock

BABA

GOOG

GOOGL

MSFT

SFTBF

Alibaba's New AI Model Outperforms OpenAI's o1 In Specific Benchmarks, Now Available For Free Download

BWLP

BW LPG Says It Takes Delivery Of Vessel BW Levant From Avance Gas; Five Of The 12 VLGCs Are Now Delivered

Japan Food Tech Holdings

Comments

Japan Food Tech Holdings

Japan Food Tech Holdings (JFTH) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga